Skip to content

Investigation of absorption of slow-release vitamin C raw materials in the body

Investigation of absorption of slow-release vitamin C raw materials in the body - Investigation of absorption of slow-release vitamin C raw materials in the body

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053585
Enrollment
10
Registered
2024-03-01
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy population

Interventions

Sustained-release vitamin C preparations Normal vitamin C preparations

Sponsors

other
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy men and women between 20 and 50 years old 2)18.5 kg/m2 or more and less than 30.0 kg/m2

Exclusion criteria

Exclusion criteria: 1)Participants with a history of serious illness or gastrointestinal surgery 2)Participants with diseases affecting gastric excretion and digestion/absorption, or with daily symptoms of indigestion, constipation, diarrhea, etc. 3)Participants with abnormal renal function, liver function, sugar or lipid metabolism 4)Participants who have concerns about their physical condition, such as headache, abdominal pain, or mental disorder. 5)Participants whose hemoglobin value is less than 11g/dl or who tend to be anemic at the most recent physical examination. 6)Participants whose total cholesterol is less than 120 mg/dl or who have a tendency to have a low appetite at the most recent physical examination. 7)Participants who regularly use medicines or supplements containing vitamin C group 8)Participants who are unable to discontinue taking medicines or supplements containing vitamin C group after obtaining consent 9)Heavy drinker or smoker of alcohol 10)Currently pregnant or lactating, or may become pregnant or lactating during the study period 11)Participants who have difficulty in having blood samples taken over time 12)Participants deemed unsuitable by the principal investigator

Design outcomes

Primary

MeasureTime frame
AUC for vitamin C concentration in blood

Secondary

MeasureTime frame
Blood vitamin C concentration at time point, Cmax, Tmax.

Countries

Japan

Contacts

Public Contactmasaya tsubokawa

FANCL Research Institute clinical trial group

tsubokawa_masaya@fancl.co.jp045-820-3659

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026